1. Familial case of hereditary Pelger-Huët anomaly

   • Tatsuya Konishi
   • Hideharu Muto
   • Junji Tomiyama

   Images in Hematology 01 June 2019 Pages: 127 - 128

   

2. Detection of Jordans’ anomaly using compact-type automated hematology analyzer

   • Tohru Inaba
   • Keita Okumura
   • Ken-ichi Hirano

   Images in Hematology 10 June 2019 Pages: 129 - 130

   

3. JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-5—diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS)

   • Ken Ohmachi

   Guide Line 08 June 2019 Pages: 131 - 146

   

4. Epigenetic abnormalities and therapies for hematological malignancies

   • Toshio Kitamura

   Progress in Hematology 06 July 2019 Pages: 147 - 149

   

5. New insights into the biology of acute myeloid leukemia with mutated NPM1

   • Lorenzo Brunetti
   • Michael C. Gundry
   • Margaret A. Goodell

   Progress in Hematology 10 January 2019 Pages: 150 - 160

   

6. Clinical update on hypomethylating agents

   • Matthieu Duchmann
   • Raphael Itzykson

   Progress in Hematology 24 April 2019 Pages: 161 - 169

   

7. Deregulated Polycomb functions in myeloproliferative neoplasms

   • Goro Sashida
   • Motohiko Oshima
   • Atsushi Iwama

   Progress in Hematology 31 January 2019 Pages: 170 - 178

   

8. Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms

   • Shuhei Asada
   • Toshio Kitamura

   Progress in Hematology 05 December 2018 Pages: 179 - 186

   

9. Hematologic recovery induced by eltrombopag in Japanese patients with aplastic anemia refractory or intolerant to immunosuppressive therapy

   • Hirohito Yamazaki
   • Kensuke Ohta
   • Shinji Nakao

   Original Article 10 June 2019 Pages: 187 - 196

   

10. Lupus anticoagulant-hypoprothrombinemia syndrome and similar diseases: experiences at a single center in Japan

    • Masahiro Ieko
    • Mika Yoshida
    • Nobuhiko Takahashi

    Original Article 04 June 2019 Pages: 197 - 204

    

11. Expression of mitochondrial genes predicts survival in pediatric acute myeloid leukemia

    • Anudishi Tyagi
    • Raja Pramanik
    • Sameer Bakhshi

    Original Article 22 May 2019 Pages: 205 - 212

    

12. Binimetinib, a novel MEK1/2 inhibitor, exerts anti-leukemic effects under inactive status of PI3Kinase/Akt pathway

    • Kanae Sakakibara
    • Takayuki Tsujioka
    • Kaoru Tohyama

    Original Article 25 May 2019 Pages: 213 - 227

    

13. Impact of chromosomal abnormalities on the efficacy of lenalidomide plus dexamethasone treatment in patients with relapsed/refractory multiple myeloma

    • Takashi Yoshida
    • Masaki Ri
    • Shinsuke Iida

    Original Article 22 May 2019 Pages: 228 - 236

    

14. Characteristics of palliative home care for patients with hematological tumors compared to those of patients with solid tumors

    • Takashi Ishida
    • Kota Ohashi
    • Takahiro Suzuki

    Original Article 31 May 2019 Pages: 237 - 243

    

15. The current state of human immunodeficiency virus-associated lymphoma in Japan: a nationwide retrospective study of the Japanese Society of Hematology Blood Disease Registry

    • Shotaro Hagiwara
    • Hirokazu Nagai
    • Seiji Okada

    Original Article 20 May 2019 Pages: 244 - 249

    

16. Hereditary spherocytosis caused by copy number variation in SPTB gene identified through targeted next-generation sequencing

    • Woori Jang
    • Jiyeon Kim
    • Yonggoo Kim

    Case Report 21 March 2019 Pages: 250 - 254

    

17. Glucocorticoids promote response to thrombopoietin-receptor agonists in refractory ITP: a case series

    • Jacqueline N. Poston
    • Terry B. Gernsheimer

    Case Report 10 April 2019 Pages: 255 - 259

18. Macrophage elimination in bone marrow by dexamethasone palmitate is associated with successful engraftment in patients with hemophagocytic syndrome

    • Hiroyuki Sugiura
    • Ken-ichi Matsuoka
    • Yoshinobu Maeda

    Letter to the Editor 16 May 2019 Pages: 260 - 262